Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril arginine + amlodipine fixed-dose combination versus perindopril monotherapy in uncontrolled primary hypertension
ChiCTR-TRC-12001986Phase 3Completed
- Sponsor
- Servier
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Perindopril arginine + amlodipine fixed-dose combination with Perindopril tert-butylamine monotherapy (2 arms). Primary endpoint: Change from baseline in sitting systolic blood pressure. Started Oct 2010; status: completed.
02
Drugs
perindoprilamlodipineperindopril tert-butylamine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-TRC-12001986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001986.